| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317161 | Clinical Biochemistry | 2015 | 6 Pages |
Abstract
A combination of graft damage biomarkers outperformed SCr in the early diagnosis of DGF, and the best performance was achieved by a triple-marker approach, using SCr, MDA, and CysC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Isabel Fonseca, Henrique Reguengo, José Carlos Oliveira, La Salete Martins, Jorge Malheiro, Manuela Almeida, Josefina Santos, LeonÃdio Dias, Sofia Pedroso, LuÃsa Lobato, António Castro Henriques, Denisa Mendonça,